Emergent BioSolutions (EBS) is up 9.7%, or 54c to $6.03.
Easter Sale - 70% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EBS:
- Emergent Biosolutions: Strong Operational Efficiency and Strategic Advancements Justify Buy Rating
- Emergent BioSolutions: Strong Q1 Performance and Strategic Growth Drive Buy Rating
- Emergent BioSolutions’ Earnings Call: A Balanced Outlook
- Emergent BioSolutions rises 29.3%
- Emergent BioSolutions rises 22.4%
